{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T02:48:54Z","timestamp":1782096534509,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T00:00:00Z","timestamp":1777161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":57,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K08902"],"award-info":[{"award-number":["22K08902"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Triple-negative breast cancer (TNBC) is an aggressive subtype characterized by high metastatic potential and limited therapeutic options. Cancer-associated fibroblasts (CAFs) promote epithelial\u2013mesenchymal transition (EMT) and metastatic progression through extracellular matrix (ECM) remodeling and TGF-\u03b2 signaling; however, the role of histamine H\n                      <jats:sub>1<\/jats:sub>\n                      receptor (H1R) signaling in CAFs remains unclear. This study investigated whether cetirizine, a clinically approved second-generation H1R antagonist, modulates CAF function and suppresses metastasis in TNBC.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Syngeneic 4T1 mouse models were used to evaluate the effects of cetirizine on tumor growth and metastasis. Bulk RNA sequencing and pathway analyses were performed on tumor tissues. Human breast cancer\u2013derived CAFs were analyzed for H1R-dependent signaling, gene expression, and cytokine production. Non-contact co-culture assays were used to assess CAF-induced migration and EMT in 4T1 cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Cetirizine improved survival in a subcutaneous TNBC model but had no effect in a lung colonization model, indicating suppression of early metastatic processes. Transcriptomic analyses revealed downregulation of ECM remodeling and fibrotic pathways. In CAFs, cetirizine inhibited H1R-dependent calcium signaling and suppressed expression of ECM genes (COL1A1, COL3A1, FN1, HSPG2) and TGFB1. These effects persisted under histamine-depleted conditions and were abolished by HRH1 knockdown, supporting inverse agonist activity. Functionally, cetirizine inhibited CAF-induced migration and EMT marker expression in 4T1 cells without direct effects on tumor cells in monoculture.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Cetirizine suppresses CAF-mediated fibrotic remodeling and EMT through H1R-dependent mechanisms, likely via inverse agonism. By targeting stromal components of the tumor microenvironment, cetirizine may represent a practical repurposing strategy for preventing early metastatic progression in TNBC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13058-026-02284-x","type":"journal-article","created":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T10:12:56Z","timestamp":1777198376000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cetirizine suppresses cancer-associated fibroblast-mediated fibrotic remodeling and epithelial\u2013mesenchymal transition via histamine H1 receptor inverse agonism"],"prefix":"10.1186","volume":"28","author":[{"given":"Aya","family":"Sasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Hosonuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Funayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Toyoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Tsurui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Tajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Orimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsunori","family":"Oguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuo","family":"Kuramasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,26]]},"reference":[{"issue":"1","key":"2284_CR1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.2174\/0115665232283880240301035621","volume":"25","author":"M Araghi","year":"2025","unstructured":"Araghi M, Gharebakhshi F, Faramarzi F, Mafi A, Mousavi T, Alimohammadi M, et al. Efficacy and safety of pembrolizumab monotherapy or combined therapy in patients with metastatic triple-negative breast cancer: a systematic review and meta-analysis of randomized controlled trials. Curr Gene Ther. 2025;25(1):72\u201388. https:\/\/doi.org\/10.2174\/0115665232283880240301035621.","journal-title":"Curr Gene Ther"},{"issue":"1","key":"2284_CR2","doi-asserted-by":"publisher","first-page":"R5","DOI":"10.1016\/s0014-2999(99)00803-1","volume":"387","author":"RA Bakker","year":"2000","unstructured":"Bakker RA, Wieland K, Timmerman H, Leurs R. Constitutive activity of the histamine H(1) receptor reveals inverse agonism of histamine H(1) receptor antagonists. Eur J Pharmacol. 2000;387(1):R5-7. https:\/\/doi.org\/10.1016\/s0014-2999(99)00803-1.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"2284_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1152\/physrev.00048.2019","volume":"101","author":"G Biffi","year":"2021","unstructured":"Biffi G, Tuveson DA. Diversity and biology of cancer-associated fibroblasts. Physiol Rev. 2021;101(1):147\u201376. https:\/\/doi.org\/10.1152\/physrev.00048.2019.","journal-title":"Physiol Rev"},{"issue":"424","key":"2284_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.canlet.2018.03.014","volume":"28","author":"P Fern\u00e1ndez-Nogueira","year":"2018","unstructured":"Fern\u00e1ndez-Nogueira P, Noguera-Castells A, Fuster G, Recalde-Percaz L, Moragas N, L\u00f3pez-Plana A, et al. Histamine receptor 1 inhibition enhances antitumor therapeutic responses through extracellular signal-regulated kinase (ERK) activation in breast cancer. Cancer Lett. 2018;28(424):70\u201383. https:\/\/doi.org\/10.1016\/j.canlet.2018.03.014.","journal-title":"Cancer Lett"},{"issue":"4","key":"2284_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101029","volume":"14","author":"I Fritz","year":"2021","unstructured":"Fritz I, Wagner P, Olsson H. Improved survival in several cancers with use of H1-antihistamines desloratadine and loratadine. Transl Oncol. 2021;14(4):101029. https:\/\/doi.org\/10.1016\/j.tranon.2021.101029.","journal-title":"Transl Oncol"},{"key":"2284_CR6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/164_2016_14","volume":"241","author":"H Fukui","year":"2017","unstructured":"Fukui H, Mizuguchi H, Nemoto H, Kitamura Y, Kashiwada Y, Takeda N. Histamine H1 receptor gene expression and drug action of antihistamines. Handb Exp Pharmacol. 2017;241:161\u20139. https:\/\/doi.org\/10.1007\/164_2016_14.","journal-title":"Handb Exp Pharmacol"},{"key":"2284_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117749","volume":"182","author":"E Funayama","year":"2025","unstructured":"Funayama E, Hosonuma M, Tajima K, Isobe J, Baba Y, Murayama M, et al. Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. Biomed Pharmacother. 2025;182:117749. https:\/\/doi.org\/10.1016\/j.biopha.2024.117749.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"2284_CR8","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3322\/caac.21863","volume":"74","author":"AN Giaquinto","year":"2024","unstructured":"Giaquinto AN, Sung H, Newman LA, Freedman RA, Smith RA, Star J, et al. Breast cancer statistics 2024. CA Cancer J Clin. 2024;74(6):477\u201395. https:\/\/doi.org\/10.3322\/caac.21863.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2284_CR9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13045-022-01347-8","volume":"15","author":"Y Huang","year":"2022","unstructured":"Huang Y, Hong W, Wei X. The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. J Hematol Oncol. 2022;15(1):129. https:\/\/doi.org\/10.1186\/s13045-022-01347-8.","journal-title":"J Hematol Oncol"},{"issue":"46","key":"2284_CR10","doi-asserted-by":"publisher","first-page":"20009","DOI":"10.1073\/pnas.1013805107","volume":"107","author":"Y Kojima","year":"2010","unstructured":"Kojima Y, Acar A, Eaton EN, Mellody KT, Scheel C, Ben-Porath I, et al. Autocrine TGF-\u03b2 and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts. Proc Natl Acad Sci U S A. 2010;107(46):20009\u201314. https:\/\/doi.org\/10.1073\/pnas.1013805107.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"2284_CR11","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1093\/bioinformatics\/btac076","volume":"38","author":"A Lachmann","year":"2022","unstructured":"Lachmann A, Xie Z, Ma\u2019ayan A. blitzGSEA: efficient computation of gene set enrichment analysis through gamma distribution approximation. Bioinformatics. 2022;38(8):2356\u20137. https:\/\/doi.org\/10.1093\/bioinformatics\/btac076.","journal-title":"Bioinformatics"},{"issue":"1","key":"2284_CR12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ccell.2021.11.002","volume":"40","author":"H Li","year":"2022","unstructured":"Li H, Xiao Y, Li Q, Yao J, Yuan X, Zhang Y, et al. The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1. Cancer Cell. 2022;40(1):36-52.e9. https:\/\/doi.org\/10.1016\/j.ccell.2021.11.002.","journal-title":"Cancer Cell"},{"issue":"7","key":"2284_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040480","volume":"7","author":"Z Liu","year":"2012","unstructured":"Liu Z, Zhang B, Liu K, Ding Z, Hu X. Schisandrin B attenuates cancer invasion and metastasis via inhibiting epithelial-mesenchymal transition. PLoS ONE. 2012;7(7):e40480. https:\/\/doi.org\/10.1371\/journal.pone.0040480.","journal-title":"PLoS ONE"},{"key":"2284_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.177704","volume":"999","author":"Y Maruyama","year":"2025","unstructured":"Maruyama Y, Hosonuma M, Toyoda H, Funayama E, Sasaki A, Baba Y, et al. Combination therapy with cetirizine and anti-PD-1 antibody suppresses colitis-induced colon tumor formation in mice. Eur J Pharmacol. 2025;999:177704. https:\/\/doi.org\/10.1016\/j.ejphar.2025.177704.","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"2284_CR15","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.201900425","volume":"2","author":"Y Matsumura","year":"2019","unstructured":"Matsumura Y, Ito Y, Mezawa Y, Sulidan K, Daigo Y, Hiraga T, et al. Stromal fibroblasts induce metastatic tumor cell clusters via epithelial-mesenchymal plasticity. Life Sci Alliance. 2019;2(4):e201900425. https:\/\/doi.org\/10.26508\/lsa.201900425.","journal-title":"Life Sci Alliance"},{"issue":"1","key":"2284_CR16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1254\/jphs.11177SC","volume":"118","author":"H Mizuguchi","year":"2012","unstructured":"Mizuguchi H, Ono S, Hattori M, Fukui H. Inverse agonistic activity of antihistamines and suppression of histamine H1 receptor gene expression. J Pharmacol Sci. 2012;118(1):117\u201321. https:\/\/doi.org\/10.1254\/jphs.11177SC.","journal-title":"J Pharmacol Sci"},{"issue":"9","key":"2284_CR17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00262-025-04111-2","volume":"74","author":"Y Narikawa","year":"2025","unstructured":"Narikawa Y, Kuramasu A, Hosonuma M, Murayama M, Funayama E, Sasaki A, et al. Inosine shapes PD-1 blockade responses and synergizes with dual PD-1\/CTLA-4 immunotherapy to enhance antitumor immunity. Cancer Immunol Immunother. 2025;74(9):289. https:\/\/doi.org\/10.1007\/s00262-025-04111-2.","journal-title":"Cancer Immunol Immunother"},{"issue":"6","key":"2284_CR18","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/sj.jid.5700253","volume":"126","author":"Y Numata","year":"2006","unstructured":"Numata Y, Terui T, Okuyama R, Hirasawa N, Sugiura Y, Miyoshi I, et al. The accelerating effect of histamine on the cutaneous wound-healing process through the action of basic fibroblast growth factor. J Invest Dermatol. 2006;126(6):1403\u20139. https:\/\/doi.org\/10.1038\/sj.jid.5700253.","journal-title":"J Invest Dermatol"},{"key":"2284_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217865","volume":"628","author":"H Sabit","year":"2025","unstructured":"Sabit H, Adel A, Abdelfattah MM, Ramadan RM, Nazih M, Abdel-Ghany S, et al. The role of tumor microenvironment and immune cell crosstalk in triple-negative breast cancer (TNBC): Emerging therapeutic opportunities. Cancer Lett. 2025;628:217865. https:\/\/doi.org\/10.1016\/j.canlet.2025.217865.","journal-title":"Cancer Lett"},{"issue":"3","key":"2284_CR20","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20(3):174\u201386. https:\/\/doi.org\/10.1038\/s41568-019-0238-1.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"2284_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-023-04760-5","volume":"80","author":"J Seo","year":"2023","unstructured":"Seo J, Park M, Ko D, Kim S, Park JM, Park S, et al. Ebastine impairs metastatic spread in triple-negative breast cancer by targeting focal adhesion kinase. Cell Mol Life Sci. 2023;80(5):132. https:\/\/doi.org\/10.1007\/s00018-023-04760-5.","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"2284_CR22","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1002\/ijc.35472","volume":"157","author":"K Tajima","year":"2025","unstructured":"Tajima K, Hosonuma M, Funayama E, Isobe J, Baba Y, Murayama M, et al. Combination therapy with levofloxacin and the probiotic Clostridium butyricum MIYAIRI 588 enhances immune checkpoint inhibitor efficacy. Int J Cancer. 2025;157(5):993\u20131005. https:\/\/doi.org\/10.1002\/ijc.35472.","journal-title":"Int J Cancer"},{"key":"2284_CR23","doi-asserted-by":"publisher","DOI":"10.2174\/0115665232373621250618181424","author":"D Tripathi","year":"2025","unstructured":"Tripathi D, Davies NM, Rajinikanth PS, Pandey P. Advancements in targeted therapies and pharmacogenomics for personalized breast cancer treatment: the role of gene SNPs in treatment resistance. Curr Gene Ther. 2025. https:\/\/doi.org\/10.2174\/0115665232373621250618181424.","journal-title":"Curr Gene Ther"},{"key":"2284_CR24","doi-asserted-by":"publisher","DOI":"10.1177\/11795549221099869","volume":"16","author":"K Uchimiak","year":"2022","unstructured":"Uchimiak K, Badowska-Kozakiewicz AM, Sobiborowicz-Sadowska A, Depta\u0142a A. Current state of knowledge on the immune checkpoint inhibitors in triple-negative breast cancer treatment: approaches, efficacy, and challenges. Clin Med Insights Oncol. 2022;16:11795549221099869. https:\/\/doi.org\/10.1177\/11795549221099869.","journal-title":"Clin Med Insights Oncol"},{"issue":"2","key":"2284_CR25","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s11010-020-03974-6","volume":"476","author":"M Wolak","year":"2021","unstructured":"Wolak M, Bojanowska E, Staszewska T, Piera L, Szyma\u0144ski J, Drobnik J. Histamine augments collagen content via H1 receptor stimulation in cultures of myofibroblasts taken from wound granulation tissue. Mol Cell Biochem. 2021;476(2):1083\u201392. https:\/\/doi.org\/10.1007\/s11010-020-03974-6.","journal-title":"Mol Cell Biochem"},{"key":"2284_CR26","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","volume":"53","author":"SZ Wu","year":"2021","unstructured":"Wu SZ, Al-Eryani G, Roden DL, et al. A single-cell and spatially resolved atlas of human breast cancers. Nat Genet. 2021;53:1334\u201347. https:\/\/doi.org\/10.1038\/s41588-021-00911-1.","journal-title":"Nat Genet"},{"key":"2284_CR27","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.pharmthera.2017.04.004","volume":"178","author":"K Yanai","year":"2017","unstructured":"Yanai K, Yoshikawa T, Yanai A, Nakamura T, Iida T, Leurs R, et al. The clinical pharmacology of non-sedating antihistamines. Pharmacol Ther. 2017;178:148\u201356. https:\/\/doi.org\/10.1016\/j.pharmthera.2017.04.004.","journal-title":"Pharmacol Ther"},{"issue":"8","key":"2284_CR28","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41580-024-00716-0","volume":"25","author":"FS Younesi","year":"2024","unstructured":"Younesi FS, Miller AE, Barker TH, Rossi FMV, Hinz B. Fibroblast and myofibroblast activation in normal tissue repair and fibrosis. Nat Rev Mol Cell Biol. 2024;25(8):617\u201338. https:\/\/doi.org\/10.1038\/s41580-024-00716-0.","journal-title":"Nat Rev Mol Cell Biol"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-026-02284-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02284-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02284-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T02:45:13Z","timestamp":1782096313000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13058-026-02284-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,26]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2284"],"URL":"https:\/\/doi.org\/10.1186\/s13058-026-02284-x","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,26]]},"assertion":[{"value":"16 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experimental protocols were approved by the Institutional Animal Care and Use Committee of Showa Medical University (approval numbers 525014 and 525016). All animal experiments were conducted in accordance with the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"113"}}